Le Lézard
Classified in: Tourism and vacations, Health
Subjects: TDS, FVT


IRVINE, Calif., May 23, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) today announced it is scheduled to present at the Bernstein 38th Annual Strategic Decisions Conference on Thursday, June 2, 2022. 

 Michael A. Mussallem, chairman and chief executive officer, is scheduled to speak to conference attendees at 1:30 p.m. ET.  A live webcast of the presentation will be available to all interested parties on the Edwards Lifesciences investor relations website at http://ir.edwards.com/.  An archived version of the webcast will be available later that day on the Edwards' investor relations website.

About Edwards Lifesciences
Edwards Lifesciences, is the global leader of patient-focused innovations for structural heart disease and critical care monitoring.  We are driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape.  For more information, visit Edwards.com and follow us on Facebook, Instagram, LinkedIn, Twitter and YouTube.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation.  All other trademarks are the property of their respective owners.


SOURCE Edwards Lifesciences Corporation

These press releases may also interest you

at 18:43
ShinyBud Corp. ("ShinyBud" or the "Company") today reported financial results for its fiscal 2023 first quarter for the three months ended April 30, 2022 (the "first quarter")....

at 18:37
The Tigard Orthopedic and Fracture Clinic (TOFC), led by Dr. Ronald Bowman, has partnered with Unity MSK and is now part of the Northwest Extremity Specialists (NES) group in Portland, OR. Unity MSK, which also partners with a large orthopedic...

at 18:22
Canopy Growth Corporation ("Canopy Growth" or the "Company") announced today that it has entered into privately negotiated exchange agreements (collectively, the "Exchange Agreements") with a limited number of holders (the "Noteholders"), including...

at 18:09
Today the President of Israel Isaac Herzog presented the Genesis Prize to Dr. Albert Bourla at a ceremony in Israel's capital Jerusalem....

at 18:09
TQIntelligence, a National Science Foundation-funded organization transforming behavioral healthcare for at-risk youth through artificial intelligence (AI) and voice recognition technology, today announces it is appointing Mark Feinberg as its new...

at 18:07
Discovery Behavioral Health, Inc., an expanding network of evidence-based mental health, substance use and eating disorder treatment centers, has appointed David Semanco as Program Director of New Life Addiction Counseling & Mental Health Services...

News published on 23 may 2022 at 08:10 and distributed by: